ACADIA Pharmaceuticals Inc. (ACAD)

AI Score

Unlock

15.38

-0.74 (-4.59%)

At close: Apr 04, 2025, 3:59 PM

15.40

0.09%

After-hours: Apr 04, 2025, 05:43 PM EDT

Dividends

No dividend history available for ACADIA Pharmaceuticals Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

ACAD News

1 week ago · Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report? - zacks.com
3 weeks ago · Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - businesswire.com
3 weeks ago · Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - businesswire.com
1 month ago · Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med - businesswire.com
1 month ago · Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates (Revised) - zacks.com
1 month ago · Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue Growth (Revised) - zacks.com
1 month ago · Acadia Pharmaceuticals Ends FY2024 On Solid Footing - seekingalpha.com
1 month ago · Acadia Pharmaceuticals to Participate in the TD Cowen's 45th Annual Health Care Conference - businesswire.com
1 month ago · Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue Growth - zacks.com
1 month ago · ACADIA Pharmaceuticals Inc. (ACAD) Q4 2024 Earnings Call Transcript - seekingalpha.com